Method of levels therapy for first-episode psychosis: rationale, design and baseline data for the feasibility randomised controlled Next Level study

Robert Griffiths, Warren Mansell, Timothy Carey, Dawn Edge, Richard Emsley, Sara Tai

    Research output: Contribution to journalArticlepeer-review

    9 Citations (Scopus)

    Abstract

    Background Method of levels (MOL) is an innovative transdiagnostic cognitive therapy with potential advantages over existing psychological treatments for psychosis.Aims The Next Level study is a feasibility randomised controlled trial (RCT) of MOL for people experiencing first-episode psychosis. It aims to determine the suitability of MOL for further testing in a definitive trial (trial registration ISRCTN13359355).Method The study uses a parallel group non-masked feasibilityRCT design with two conditions: (a) treatment as usual (TAU) and (b) TAU plus MOL. Participants (n = 36) were recruited from early intervention in psychosis services. Outcome measures are completed at baseline, 10 and 14 months. The primary outcomes are recruitment and retention.Results Participants' demographic and clinical characteristics are presented along with baseline data.Conclusions Next Level has recruited to target, providing evidence that it is feasible to recruit to a RCT of MOL for first-episode psychosis.

    Original languageEnglish
    Pages (from-to)339-345
    Number of pages7
    JournalBJPsych Open
    Volume4
    Issue number5
    DOIs
    Publication statusPublished - 1 Sep 2018

    Keywords

    • feasibility
    • first-episode psychosis
    • Method of Levels
    • randomised controlled trial

    Fingerprint Dive into the research topics of 'Method of levels therapy for first-episode psychosis: rationale, design and baseline data for the feasibility randomised controlled Next Level study'. Together they form a unique fingerprint.

    Cite this